CD8A and myeloid sarcoma: Notably, a lower proportion of memory CD8+ T cell subsets (particularly effector memory and TEMRA) has been observed in patients with untreated RRMS than in HC, probably due to inherent (i.e., genetically determined) defects rather than a pathophysiological effect of MS (28, 29).